Insight

Sumanta K. Pal: Interesting interplay between microbiome and HIF2 pathways

Photo from Sumanta K. Pal/X

Aug 2, 2024, 05:45

Sumanta K. Pal: Interesting interplay between microbiome and HIF2 pathways

Sumanta K. Pal shared a post by Yi Zhang et al. on X, adding:

“Interesting interplay between microbiome and HIF2 pathways.

Any implications for kidney cancer, perhaps in the context of belzutifan therapy?

Could the effect of R. torques extend beyond the gut?

Food for thought (pun intended).”

Sumanta K. Pal

Source: Sumanta K. Pal/X

Authors: Yi Zhang, Xuemei Wang, Jun Lin, Jia Liu, Kai Wang, Qixing Nie, Chuan Ye, Lulu Sun, Yanpeng Ma, Ruize Qu, Yuejian Mao, Xuguang Zhang, Hua Lu, Pengyan Xia, Dongyu Zhao, Guang Wang, Zhipeng Zhang, Wei Fu, Changtao Jiang, and Yanli Pang

Sumanta K. Pal

belzutifan cancer Changtao Jiang Chuan Ye Dongyu Zhao Guang Wang HIF2 pathways Hua Lu Jia Liu Jun Lin Kai Wang kidney cancer Lulu Sun OncoDaily Oncology Pengyan Xia Qixing Nie Ruize Qu Sumanta K. Pal Wei Fu Xuemei Wang Xuguang Zhang Yanli Pang Yanpeng Ma Yi Zhang Yuejian Mao Zhipeng Zhang

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage